Evidence map›Paper›PMID 36645508›Full record

ArticleJournal of cancer research and clinical oncology2023

An automatic classification of pulmonary nodules for lung cancer diagnosis using novel LLXcepNN classifier.

Vijay Kumar Gugulothu, Savadam Balaji

Abstract read
In one paragraph

Article in Journal of cancer research and clinical oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Vijay Kumar GugulothuDepartment of Computer Science & Engineering, Koneru Lakshmaiah Education Foundation, Deemed to be University and Govt. Polytechnic, Masab Tank, Hyderabad, Telangana, India. vijaykumargugulothu@klh.edu.in.
Savadam BalajiDepartment of Computer Science & Engineering, Koneru Lakshmaiah Education Foundation, Deemed to be University and Govt. Polytechnic, Masab Tank, Hyderabad, Telangana, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionA critical step to ameliorate diagnosis and extend patient survival is Benign-malignant Pulmonary Nodule (PN) classification at earlier detection. On account of the noise of Computed Tomography (CT) images, the prevailing Lung Nodule (LN) detection techniques exhibit broad variation in accurate prediction.

methodsThus, a novel Nodule Detection along with Classification algorithm for early diagnosis of Lung Cancer (LC) has been proposed. Initially, employing the Adaptive Mode Ostu Binarization (AMOB) technique, the Lung Volumes (LVs) isextortedas of the image together with the extracted lung regions is pre-processed. Then, detection of LNs takes place, and utilizing Geodesic Fuzzy C-Means Clustering (GFCM) Segmentation Algorithm, it is segmented.Next, the vital features are extracted, and the Nodules are classified by utilizing Logarithmic Layer Xception Neural Network (LLXcepNN) Classifier grounded on the extracted feature.

resultsThe nodules are classified as Benign Nodules (BN) and Malignant Nodules (MN) by the proposed classifier. Lastly, the Lung CT images are scrutinized. DISCUSSION: Thus, when weighed against the prevailing techniques, the proposed systems' acquired outcomes exhibit that the rate of accuracy of classification is enhanced.

Indexed as

Lung NeoplasmsMultiple Pulmonary NodulesAlgorithmsHumansLungNeural Networks, ComputerTomography, X-Ray ComputedAdaptive Mode Ostu Binarization (AMOB)Geodesic Fuzzy C-Means Clustering (GFCM)Logarithmic Layer Xception Neural Network (LLXcepNN)Median filter and Contrast Limited Adaptive Histogram Equalization (CLAHE)

Identifiers

PMID36645508
PMCPMC11797126

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.